Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hartley

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Journal of Receptor and Signal Transduction Research|December 31, 2002
The use of phage display in the study of receptors and their ligandsOliver Hartley
Chimia|June 30, 2017
Recombinant Antibodies for Academia: A Practical ApproachPierre Cosson, Oliver Hartley
Annual Review of Pharmacology and Toxicology|October 17, 2007
Targeting chemokine receptors in HIV: a status reportShawn E Kuhmann, Oliver Hartley
Current Protein & Peptide Science|June 25, 2005
Engineering chemokines to develop optimized HIV inhibitorsOliver Hartley, Robin E Offord
Biopolymers|February 15, 2008
Characterization of new multimeric erythropoietin receptor agonistsOscar Vadas, Oliver Hartley, Keith Rose
Structure (London, England : 1993)|April 18, 2006
HIV-1 coreceptor selectivity: structural analogy between HIV-1 V3 regions and chemokine beta-hairpins is not the explanationHolger Scheib, Peter Sperisen, Oliver Hartley
Biophysical Journal|December 10, 2013
Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTESMaciej Wiktor, Oliver Hartley, Stephan Grzesiek
World Journal of Cardiology|June 20, 2014
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunityNicolas Vuilleumier, Fabrizio Montecucco, Oliver Hartley
Cytokine|June 16, 2018
CCR5: Established paradigms and new frontiers for a 'celebrity' chemokine receptorIlaria Scurci, Elsa Martins, Oliver Hartley
Swiss Medical Weekly|January 30, 2018
Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectivesOliver Hartley, Elsa Martins, Ilaria Scurci
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Journal of Receptor and Signal Transduction Research|December 31, 2002
The use of phage display in the study of receptors and their ligandsOliver Hartley
Chimia|June 30, 2017
Recombinant Antibodies for Academia: A Practical ApproachPierre Cosson, Oliver Hartley
Annual Review of Pharmacology and Toxicology|October 17, 2007
Targeting chemokine receptors in HIV: a status reportShawn E Kuhmann, Oliver Hartley
Current Protein & Peptide Science|June 25, 2005
Engineering chemokines to develop optimized HIV inhibitorsOliver Hartley, Robin E Offord
Biopolymers|February 15, 2008
Characterization of new multimeric erythropoietin receptor agonistsOscar Vadas, Oliver Hartley, Keith Rose
Structure (London, England : 1993)|April 18, 2006
HIV-1 coreceptor selectivity: structural analogy between HIV-1 V3 regions and chemokine beta-hairpins is not the explanationHolger Scheib, Peter Sperisen, Oliver Hartley
Biophysical Journal|December 10, 2013
Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTESMaciej Wiktor, Oliver Hartley, Stephan Grzesiek
World Journal of Cardiology|June 20, 2014
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunityNicolas Vuilleumier, Fabrizio Montecucco, Oliver Hartley
Cytokine|June 16, 2018
CCR5: Established paradigms and new frontiers for a 'celebrity' chemokine receptorIlaria Scurci, Elsa Martins, Oliver Hartley
Swiss Medical Weekly|January 30, 2018
Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectivesOliver Hartley, Elsa Martins, Ilaria Scurci
Pageof 9